Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality
Open Access
- 28 September 2011
- journal article
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 19 (1) , 52
Abstract
Introduction: Exsanguination due to uncontrolled bleeding is the leading cause of potentially preventable deaths among trauma patients. About one third of trauma patients present with coagulopathy on admission, which is associated with increased mortality and will aggravate bleeding in a traumatized patient. Thrombelastographic (TEG) clot strength has previously been shown to predict outcome in critically ill patients. The aim of the present study was to investigate this relation in the trauma setting. Methods: A retrospective study of trauma patients with an injury severity qualifying them for inclusion in the European Trauma Audit and Research Network (TARN) and a TEG analysis performed upon arrival at the trauma centre. Results: Eighty-nine patients were included. The mean Injury Severity Score (ISS) was 21 with a 30-day mortality of 17%. Patients with a reduced clot strength (maximal amplitude < 50 mm) evaluated by TEG, presented with a higher ISS 27 (95% CI, 20-34) vs. 19 (95% CI, 17-22), p = 0.006 than the rest of the cohort. Clot strength correlated with the amount of packed red blood cells (p = 0.01), fresh frozen plasma (p = 0.04) and platelet concentrates (p = 0.03) transfused during the first 24 hours of admission. Patients with low clot strength demonstrated increased 30-day mortality (47% vs. 10%, p < 0.001). By logistic regression analysis reduced clot strength was an independent predictor of increased mortality after adjusting for age and ISS. Conclusion: Low clot strength upon admission is independently associated with increased 30-day mortality in trauma patients and it could be speculated that targeted interventions based on the result of the TEG analysis may improve patient outcome. Prospective randomized trials investigating this potential are highly warranted.Keywords
This publication has 37 references indexed in Scilit:
- A High Admission Syndecan-1 Level, A Marker of Endothelial Glycocalyx Degradation, Is Associated With Inflammation, Protein C Depletion, Fibrinolysis, and Increased Mortality in Trauma PatientsAnnals of Surgery, 2011
- Initial experiences with point‐of‐care rapid thrombelastography for management of life‐threatening postinjury coagulopathyTransfusion, 2011
- Acute coagulopathy of trauma: Balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulationMedical Hypotheses, 2010
- Primary Fibrinolysis Is Integral in the Pathogenesis of the Acute Coagulopathy of TraumaAnnals of Surgery, 2010
- Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrateCritical Care, 2010
- Management of bleeding following major trauma: an updated European guidelineCritical Care, 2010
- Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after studyVox Sanguinis, 2009
- Thrombelastography and tromboelastometry in assessing coagulopathy in traumaScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2009
- Early Predictors of Transfusion and Mortality After Injury: A Review of the Data-Based LiteratureJournal of Trauma: Injury, Infection & Critical Care, 2006
- A Cell-Based Model of Thrombin GenerationSeminars in Thrombosis and Hemostasis, 2006